Abiopharma

🔍 CASPER MARC N (Director)

Company: THERMO FISHER SCIENTIFIC INC. (TMO)

Report Date: 2026-08-06

Detailed Transactions and Holdings:

• Acquired 10,000 shares of Common Stock at $309.63 per share (Direct)
  Date: 2026-08-06 | Code: M | equity_swap_involved: 0 | shares_owned_after: 133,925.36 | transaction_form_type: 4
• Sold 480 shares of Common Stock at $571.05 per share (Direct)
  Date: 2026-08-06 | Code: S | equity_swap_involved: 0 | shares_owned_after: 133,445.36 | transaction_form_type: 4 | Footnotes: F1, F2
• Sold 1,631 shares of Common Stock at $572.43 per share (Direct)
  Date: 2026-08-06 | Code: S | equity_swap_involved: 0 | shares_owned_after: 131,814.36 | transaction_form_type: 4 | Footnotes: F1, F3
• Sold 2,545 shares of Common Stock at $573.53 per share (Direct)
  Date: 2026-08-06 | Code: S | equity_swap_involved: 0 | shares_owned_after: 129,269.36 | transaction_form_type: 4 | Footnotes: F1, F4
• Sold 1,617 shares of Common Stock at $574.4 per share (Direct)
  Date: 2026-08-06 | Code: S | equity_swap_involved: 0 | shares_owned_after: 127,652.36 | transaction_form_type: 4 | Footnotes: F1, F5
• Sold 2,164 shares of Common Stock at $575.46 per share (Direct)
  Date: 2026-08-06 | Code: S | equity_swap_involved: 0 | shares_owned_after: 125,488.36 | transaction_form_type: 4 | Footnotes: F1, F6
• Sold 480 shares of Common Stock at $576.46 per share (Direct)
  Date: 2026-08-06 | Code: S | equity_swap_involved: 0 | shares_owned_after: 125,008.36 | transaction_form_type: 4 | Footnotes: F1, F7
• Sold 451 shares of Common Stock at $577.43 per share (Direct)
  Date: 2026-08-06 | Code: S | equity_swap_involved: 0 | shares_owned_after: 124,557.36 | transaction_form_type: 4 | Footnotes: F1, F8
• Sold 321 shares of Common Stock at $578.67 per share (Direct)
  Date: 2026-08-06 | Code: S | equity_swap_involved: 0 | shares_owned_after: 124,236.36 | transaction_form_type: 4 | Footnotes: F1, F9
• Sold 311 shares of Common Stock at $579.9 per share (Direct)
  Date: 2026-08-06 | Code: S | equity_swap_involved: 0 | shares_owned_after: 123,925.36 | transaction_form_type: 4 | Footnotes: F1, F10
• Sold 240 shares of Common Stock at $571.0 per share (Direct)
  Date: 2026-08-06 | Code: S | equity_swap_involved: 0 | shares_owned_after: 9,368.00 | transaction_form_type: 4 | Footnotes: F1, F11
• Sold 660 shares of Common Stock at $572.33 per share (Direct)
  Date: 2026-08-06 | Code: S | equity_swap_involved: 0 | shares_owned_after: 8,708.00 | transaction_form_type: 4 | Footnotes: F1, F12
• Sold 1,200 shares of Common Stock at $573.34 per share (Direct)
  Date: 2026-08-06 | Code: S | equity_swap_involved: 0 | shares_owned_after: 7,508.00 | transaction_form_type: 4 | Footnotes: F1, F13
• Sold 1,008 shares of Common Stock at $574.28 per share (Direct)
  Date: 2026-08-06 | Code: S | equity_swap_involved: 0 | shares_owned_after: 6,500.00 | transaction_form_type: 4 | Footnotes: F1, F14
• Sold 1,060 shares of Common Stock at $575.41 per share (Direct)
  Date: 2026-08-06 | Code: S | equity_swap_involved: 0 | shares_owned_after: 5,440.00 | transaction_form_type: 4 | Footnotes: F1, F15
• Sold 225 shares of Common Stock at $576.09 per share (Direct)
  Date: 2026-08-06 | Code: S | equity_swap_involved: 0 | shares_owned_after: 5,215.00 | transaction_form_type: 4 | Footnotes: F1, F16
• Sold 361 shares of Common Stock at $577.57 per share (Direct)
  Date: 2026-08-06 | Code: S | equity_swap_involved: 0 | shares_owned_after: 4,854.00 | transaction_form_type: 4 | Footnotes: F1, F17
• Sold 119 shares of Common Stock at $578.93 per share (Direct)
  Date: 2026-08-06 | Code: S | equity_swap_involved: 0 | shares_owned_after: 4,735.00 | transaction_form_type: 4 | Footnotes: F1, F18
• Sold 127 shares of Common Stock at $580.01 per share (Direct)
  Date: 2026-08-06 | Code: S | equity_swap_involved: 0 | shares_owned_after: 4,608.00 | transaction_form_type: 4 | Footnotes: F1, F19
• Sold 10,000 shares of Stock Option (Right to Buy) at $309.63 per share (Derivative)
  Date: 2026-08-06 | Code: M | Expires: 2027-02-25 | equity_swap_involved: 0 | shares_owned_after: 20,550.00 | transaction_form_type: 4 | Footnotes: F20

Footnotes:

• F1: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on April 27, 2026.
• F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $570.56 to $571.53, inclusive. The reporting person undertakes to provide to Thermo Fisher Scientific Inc. ("TMO"), any security holder of TMO or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (3), (4), (5), (6), (7), (8), (9), (10), (11), (12), (13), (14), (15), (16), (17), (18) and (19) to this Form 4.
• F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $571.83 to $572.78, inclusive.
• F4: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $572.94 to $573.93, inclusive.
• F5: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $573.94 to $574.92, inclusive.
• F6: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $575.00 to $575.95, inclusive.
• F7: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $576.10 to $577.03, inclusive.
• F8: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $577.14 to $578.13, inclusive.
• F9: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $578.14 to $579.13, inclusive.
• F10: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $579.28 to $580.07, inclusive.
• F11: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $570.56 to $571.45, inclusive.
• F12: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $571.70 to $572.67, inclusive.
• F13: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $572.90 to $573.87, inclusive.
• F14: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $573.91 to $574.70, inclusive.
• F15: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $575.02 to $576.01, inclusive.
• F16: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $576.08 to $576.11, inclusive.
• F17: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $577.18 to $578.06, inclusive.
• F18: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $578.54 to $579.11, inclusive.
• F19: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $579.97 to $580.06, inclusive.
• F20: The option vested in four equal installments on February 25, 2021, 2022, 2023, and 2024.
• REMARKS: One of two Form 4's filed on August 7, 2026 for the reporting of transactions occurring on August 5 and August 6, 2026. The first Form 4 includes transactions occurring on August 5, 2026, and the second Form 4 includes transactions occurring on August 6, 2026. In aggregate, all transactions could not be included in the first Form 4 due to a limitation on the number of line items that can be included per table in a single Form 4.